• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

量化对抗癫痫药物的反应:既往治疗史的影响。

Quantifying the response to antiepileptic drugs: effect of past treatment history.

作者信息

Schiller Yitzhak, Najjar Yussef

机构信息

Department of Neurology, Rambam Medical Center, 1 Efron St., Haifa, Israel.

出版信息

Neurology. 2008 Jan 1;70(1):54-65. doi: 10.1212/01.wnl.0000286959.22040.6e.

DOI:10.1212/01.wnl.0000286959.22040.6e
PMID:18166707
Abstract

OBJECTIVE

To quantify the response to treatment with antiepileptic drugs (AEDs) as a function of the past treatment history and identify additional prognostic factors for predicting the response to newly administered AED treatments.

METHODS

A cohort of 478 consecutive patients who received newly administered AED treatments between January 1999 and December 2004 and were followed prospectively for 1.5 to 7.5 years in a single epilepsy clinic.

RESULTS

The response to newly administered AED treatments was highly dependent on the past treatment history. The seizure-free rates decreased from 61.8% for the first AED to 41.7%, 16.6%, and 0% after one, two to five, and six to seven past AEDs proved inefficient. This response curve corresponded to a mono-exponential function with a maximal response of 61.8% and half-decay constant of 1.5 AEDs. Likewise the response curve describing a greater than 50% reduction in seizure frequency corresponded to a mono-exponential function with a maximal response of 85.3% and half-decay constant of two AEDs. Three additional independent prognostic factors for predicting the response to AEDs were identified: type of epilepsy, duration of epilepsy, and number of seizures in the 3 months prior to AED initiation.

CONCLUSION

Drug resistance is a graded process that follows a mono-exponential course with a half-decay constant of 1.5 to two antiepileptic drugs (AEDs). Although relative drug-resistant epilepsy can be diagnosed after failure of two past AEDs, absolute drug resistance requires failure of six AEDs, as a significant minority of patients (16.6%) is rendered seizure-free by addition of newly administered AEDs even after failure of two to five past antiepileptic drugs.

摘要

目的

根据既往治疗史对使用抗癫痫药物(AEDs)治疗的反应进行量化,并确定预测新给予的AEDs治疗反应的其他预后因素。

方法

对1999年1月至2004年12月期间连续接受新给予AEDs治疗的478例患者进行队列研究,并在单一癫痫诊所进行了1.5至7.5年的前瞻性随访。

结果

对新给予的AEDs治疗的反应高度依赖于既往治疗史。首次使用AED时无癫痫发作率为61.8%,在既往一种、两种至五种以及六种至七种AED治疗无效后,无癫痫发作率分别降至41.7%、16.6%和0%。该反应曲线符合单指数函数,最大反应为61.8%,半衰期常数为1.5种AEDs。同样,描述癫痫发作频率降低超过50%的反应曲线也符合单指数函数,最大反应为85.3%,半衰期常数为两种AEDs。确定了另外三个预测AEDs治疗反应的独立预后因素:癫痫类型、癫痫持续时间以及开始使用AED前3个月内癫痫发作次数。

结论

耐药性是一个分级过程,遵循单指数过程,半衰期常数为1.5至两种抗癫痫药物(AEDs)。虽然在既往两种AED治疗失败后可诊断为相对耐药性癫痫,但绝对耐药性需要六种AED治疗失败,因为即使在既往两至五种抗癫痫药物治疗失败后,仍有相当一部分患者(16.6%)通过加用新给予的AEDs实现无癫痫发作。

相似文献

1
Quantifying the response to antiepileptic drugs: effect of past treatment history.量化对抗癫痫药物的反应:既往治疗史的影响。
Neurology. 2008 Jan 1;70(1):54-65. doi: 10.1212/01.wnl.0000286959.22040.6e.
2
The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy.癫痫发作已得到控制的儿童停用抗癫痫药物(AEDs)后难治性癫痫发作的频率。
Neurology. 2005 Mar 22;64(6):973-5. doi: 10.1212/01.WNL.0000154517.82748.A7.
3
How reliable is early treatment response in predicting long-term seizure outcome?早期治疗反应在预测长期癫痫发作结果方面的可靠性如何?
Epilepsy Behav. 2007 Jun;10(4):588-94. doi: 10.1016/j.yebeh.2007.02.011. Epub 2007 Apr 5.
4
Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.成人患者在两个癫痫中心就诊的局灶性癫痫:耐药性分类、危险因素评估和“新型”抗癫痫药物的作用。
Epilepsia. 2012 Apr;53(4):733-40. doi: 10.1111/j.1528-1167.2012.03416.x. Epub 2012 Feb 23.
5
Discontinuation and duration of antiepileptic drug therapy: a retrospective study of factors for specific epileptic syndromes.抗癫痫药物治疗的停药与疗程:特定癫痫综合征相关因素的回顾性研究
Epilepsia. 2004;45 Suppl 8:26-32. doi: 10.1111/j.0013-9580.2004.458006.x.
6
Early versus late remission in a cohort of patients with newly diagnosed epilepsy.新诊断癫痫患者队列中的早期缓解与晚期缓解。
Epilepsia. 2010 Jan;51(1):37-42. doi: 10.1111/j.1528-1167.2009.02141.x. Epub 2009 Jun 1.
7
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.在一个大型耐药性癫痫患者连续队列中,抗癫痫药物不良反应、合并用药数量与药物负荷之间的关系。
Epilepsia. 2010 May;51(5):797-804. doi: 10.1111/j.1528-1167.2010.02520.x. Epub 2010 Apr 20.
8
Seizure relapse and development of drug resistance following long-term seizure remission.长期癫痫发作缓解后的癫痫复发及耐药性发展。
Arch Neurol. 2009 Oct;66(10):1233-9. doi: 10.1001/archneurol.2009.211.
9
Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus Study).抗癫痫药物撤药的后果:一项随机双盲研究(阿克什胡斯研究)
Epilepsia. 2008 Mar;49(3):455-63. doi: 10.1111/j.1528-1167.2007.01323.x. Epub 2007 Sep 19.
10
Epileptic seizures during follow-up of patients treated for primary brain tumors.原发性脑肿瘤治疗患者随访期间的癫痫发作
Neurology. 2005 Jul 26;65(2):212-5. doi: 10.1212/01.wnl.0000168903.09277.8f.

引用本文的文献

1
Real-world utilization of Cenobamate as adjunct therapy in office-based neurology: practical tips and insights for titration.在门诊神经病学中作为辅助疗法的司替戊醇的真实世界应用:滴定的实用技巧与见解
Front Neurol. 2025 Jun 13;16:1558614. doi: 10.3389/fneur.2025.1558614. eCollection 2025.
2
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study.吡仑帕奈作为高度活跃性癫痫唯一辅助抗癫痫药物的有效性:来自一项真实世界、多中心回顾性研究的见解
J Neurol. 2025 Jun 7;272(7):449. doi: 10.1007/s00415-025-13184-z.
3
Real-world effectiveness and tolerability of cenobamate in drug-resistant epilepsy: A retrospective analysis of the patients included into the Early Access Programs (EAP) in Germany, France, and United Kingdom.
司替戊醇在耐药性癫痫中的真实世界有效性和耐受性:对德国、法国和英国早期准入项目(EAP)纳入患者的回顾性分析。
Epilepsia Open. 2025 Mar 22. doi: 10.1002/epi4.70021.
4
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study.辅助用司替戊醇治疗局灶性癫痫患者的有效性和安全性:来自BLESS研究24周观察期的中期结果。
Epilepsia. 2025 Jul;66(7):2239-2252. doi: 10.1111/epi.18357. Epub 2025 Mar 15.
5
Long-term safety and efficacy of adjunctive lacosamide in the treatment of generalized onset tonic-clonic seizures: An open-label extension trial.辅助用拉科酰胺治疗全面性强直阵挛发作的长期安全性和有效性:一项开放标签延长期试验。
Epilepsia. 2024 Dec;65(12):3488-3500. doi: 10.1111/epi.18158. Epub 2024 Oct 26.
6
Long-Term Outcome in Adult Patients with Drug-Resistant Epilepsy Submitted to Vagus Nerve Stimulation.接受迷走神经刺激的耐药性癫痫成年患者的长期预后
Brain Sci. 2024 Jun 26;14(7):639. doi: 10.3390/brainsci14070639.
7
Treatment simplification to optimize cenobamate effectiveness and tolerability: A real-world retrospective study in Spain.简化治疗以优化依诺加酯的疗效和耐受性:西班牙的一项真实世界回顾性研究。
Epilepsia Open. 2024 Aug;9(4):1345-1356. doi: 10.1002/epi4.12959. Epub 2024 May 27.
8
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records.12 个月布瓦西坦的有效性和耐受性:EXPERIENCE,一项国际个体患者记录的汇总分析。
CNS Drugs. 2023 Sep;37(9):819-835. doi: 10.1007/s40263-023-01033-4. Epub 2023 Sep 9.
9
Revisiting the concept of drug-resistant epilepsy: A TASK1 report of the ILAE/AES Joint Translational Task Force.重新审视耐药性癫痫的概念:ILAE/AES 联合转化工作组的 TASK1 报告。
Epilepsia. 2023 Nov;64(11):2891-2908. doi: 10.1111/epi.17751. Epub 2023 Sep 7.
10
Demographic and Clinical Predictors of Drug Response in Epileptic Children in Jeddah.吉达癫痫儿童药物反应的人口统计学和临床预测因素
Biomedicines. 2023 Jul 30;11(8):2151. doi: 10.3390/biomedicines11082151.